Drug use trends, drug development and markets historically move faster than research and policy responses.
Our work with Anex and Lucid provides us with on-the-ground knowledge. Using this front-line experience, we collaborate with community groups, health and emergency service organisations, research bodies, the private sector and governments to translate this knowledge into action.
For instance the Victorian Government responded to early reports about increasing crystal methamphetamine use in 2013 by commissioning a community assessment of the effects the drug was having across the state.
Anex was approached to conduct the assessment. The report from this assessment is due to be handed to government in 2014.
Penington Institute analyses the best evidence based research to inform debate about what does and doesn’t work and provides a base for effective policy and community response.
Below are a selection of just some of our reports, undertaken by our programs:
- Australia’s Annual Overdose Report 2017
- Not just naloxone: Insights into emerging models to reduce drug harms
- A community controlled approach to problematic ice use – Penington Institute
- Chronic Unfairness – Penington Institute
- Australia’s Annual Overdose Report 2016
- The Seventh National HIV/AIDS Strategy 2014 -2017 – Penington Institute comments
- The Fourth National Hepatitis C Virus Strategy 2014-2017 – Penington Institute comments
- The Second National Hepatitis B Strategy 2014-2017 – Penington Institute comments
- Anex submission to the Law Reform, Drugs and Crime Prevention Committee Inquiry into the supply and use of methamphetamine, particularly ‘ice’
- Victorian alcohol and other drug treatment principles consultation paper
- An Australian ‘new recovery’?
- A proposed Australian definition of Recovery and principles
- Access to naloxone
- Needle and syringe program (NSP) in prisons
- Find out more about Prison NSPs’
- Improving needle and syringe program (NSP) access
- Aboriginal health
- Report from ‘Harmaceuticals: special forum on fentanyl injection and overdoses’
- Previous policy and research highlights